(JD) JD.com - Overview
Stock: Retail, Logistics, Marketplace, Healthcare, Supply Chain
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.97% |
| Yield on Cost 5y | 1.14% |
| Yield CAGR 5y | -7.54% |
| Payout Consistency | 89.2% |
| Payout Ratio | 4.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 32.0% |
| Relative Tail Risk | -13.0% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.84 |
| Alpha | -43.36 |
| Character TTM | |
|---|---|
| Beta | 0.768 |
| Beta Downside | 0.766 |
| Drawdowns 3y | |
|---|---|
| Max DD | 60.77% |
| CAGR/Max DD | -0.32 |
Description: JD JD.com January 28, 2026
JD.com, Inc. (NASDAQ:JD) is a China-based, supply-chain-focused technology and service company that operates three core segments: JD Retail (direct e-commerce sales), JD Logistics (ownership and operation of a nationwide logistics network), and New Businesses (including third-party marketplace services, omni-channel solutions, and online healthcare). The firm sells a broad catalog ranging from electronics and appliances to fresh food, apparel, and pharmaceuticals, and it also offers logistics infrastructure, storage leasing, and asset-management services to third parties.
Key recent metrics (FY 2025): revenue of ¥1.42 trillion, up 12% YoY, driven by a 15% increase in active customer accounts (now ~620 million) and a 9% rise in gross merchandise volume (GMV) on its marketplace platform. JD’s logistics arm now operates >1,200 fulfillment centers covering 95% of China’s population, with same-day delivery capability in 300+ cities-a critical advantage amid China’s post-COVID consumer-spending rebound and accelerating e-commerce penetration (currently ~25% of total retail sales). Sector-wide, AI-enabled supply-chain automation is expected to lift operating margins for top-tier Chinese retailers by 1-2 percentage points over the next two years.
For a deeper, data-driven assessment of JD.com’s valuation dynamics, you may find the ValueRay analysis worth a quick look.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 32.20b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -5.46 > 1.0 |
| NWC/Revenue: 4.81% < 20% (prev 4.07%; Δ 0.74% < -1%) |
| CFO/TA 0.03 > 3% & CFO 23.00b > Net Income 32.20b |
| Net Debt (-980.0m) to EBITDA (43.93b): -0.02 < 3 |
| Current Ratio: 1.20 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.48b) vs 12m ago -2.21% < -2% |
| Gross Margin: 12.73% > 18% (prev 0.14%; Δ 1259 % > 0.5%) |
| Asset Turnover: 192.1% > 50% (prev 173.7%; Δ 18.44% > 0%) |
| Interest Coverage Ratio: 12.85 > 6 (EBITDA TTM 43.93b / Interest Expense TTM 2.90b) |
Altman Z'' 1.92
| A: 0.09 (Total Current Assets 379.26b - Total Current Liabilities 316.55b) / Total Assets 713.53b |
| B: 0.12 (Retained Earnings 83.26b / Total Assets 713.53b) |
| C: 0.05 (EBIT TTM 37.24b / Avg Total Assets 678.54b) |
| D: 0.57 (Book Value of Equity 231.93b / Total Liabilities 409.11b) |
| Altman-Z'' Score: 1.92 = BBB |
Beneish M -2.43
| DSRI: 1.55 (Receivables 41.49b/22.89b, Revenue 1303.79b/1117.91b) |
| GMI: 1.10 (GM 12.73% / 14.06%) |
| AQI: 0.86 (AQ_t 0.29 / AQ_t-1 0.34) |
| SGI: 1.17 (Revenue 1303.79b / 1117.91b) |
| TATA: 0.01 (NI 32.20b - CFO 23.00b) / TA 713.53b) |
| Beneish M-Score: -2.43 (Cap -4..+1) = BBB |
What is the price of JD shares?
Over the past week, the price has changed by -6.02%, over one month by -7.86%, over three months by -14.73% and over the past year by -29.39%.
Is JD a buy, sell or hold?
- StrongBuy: 28
- Buy: 7
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the JD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 40.9 | 49.7% |
| Analysts Target Price | 40.9 | 49.7% |
| ValueRay Target Price | 23.8 | -13% |
JD Fundamental Data Overview January 31, 2026
P/E Trailing = 9.4428
P/E Forward = 10.6157
P/S = 0.0327
P/B = 1.2369
P/EG = 1.2717
Revenue TTM = 1303.79b CNY
EBIT TTM = 37.24b CNY
EBITDA TTM = 43.93b CNY
Long Term Debt = 59.96b CNY (from longTermDebt, last quarter)
Short Term Debt = 29.51b CNY (from shortTermDebt, last quarter)
Debt = 112.09b CNY (from shortLongTermDebtTotal, last quarter)
Net Debt = -980.0m CNY (from netDebt column, last quarter)
Enterprise Value = 209.76b CNY (295.94b + Debt 112.09b - CCE 198.27b)
Interest Coverage Ratio = 12.85 (Ebit TTM 37.24b / Interest Expense TTM 2.90b)
EV/FCF = 170.1x (Enterprise Value 209.76b / FCF TTM 1.23b)
FCF Yield = 0.59% (FCF TTM 1.23b / Enterprise Value 209.76b)
FCF Margin = 0.09% (FCF TTM 1.23b / Revenue TTM 1303.79b)
Net Margin = 2.47% (Net Income TTM 32.20b / Revenue TTM 1303.79b)
Gross Margin = 12.73% ((Revenue TTM 1303.79b - Cost of Revenue TTM 1137.83b) / Revenue TTM)
Gross Margin QoQ = 9.52% (prev 15.88%)
Tobins Q-Ratio = 0.29 (Enterprise Value 209.76b / Total Assets 713.53b)
Interest Expense / Debt = 0.65% (Interest Expense 730.0m / Debt 112.09b)
Taxrate = 3.80% (252.0m / 6.63b)
NOPAT = 35.83b (EBIT 37.24b * (1 - 3.80%))
Current Ratio = 1.20 (Total Current Assets 379.26b / Total Current Liabilities 316.55b)
Debt / Equity = 0.48 (Debt 112.09b / totalStockholderEquity, last quarter 231.93b)
Debt / EBITDA = -0.02 (Net Debt -980.0m / EBITDA 43.93b)
Debt / FCF = -0.79 (Net Debt -980.0m / FCF TTM 1.23b)
Total Stockholder Equity = 233.19b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.75% (Net Income 32.20b / Total Assets 713.53b)
RoE = 13.81% (Net Income TTM 32.20b / Total Stockholder Equity 233.19b)
RoCE = 12.70% (EBIT 37.24b / Capital Employed (Equity 233.19b + L.T.Debt 59.96b))
RoIC = 11.85% (NOPAT 35.83b / Invested Capital 302.42b)
WACC = 6.52% (E(295.94b)/V(408.03b) * Re(8.75%) + D(112.09b)/V(408.03b) * Rd(0.65%) * (1-Tc(0.04)))
Discount Rate = 8.75% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -3.18%
[DCF Debug] Terminal Value 83.71% ; FCFF base≈15.24b ; Y1≈15.11b ; Y5≈15.72b
Fair Price DCF = 275.2 (EV 389.57b - Net Debt -980.0m = Equity 390.55b / Shares 1.42b; r=6.52% [WACC]; 5y FCF grow -1.58% → 2.90% )
EPS Correlation: -19.26 | EPS CAGR: -37.23% | SUE: -0.98 | # QB: 0
Revenue Correlation: 62.50 | Revenue CAGR: 2.17% | SUE: 0.02 | # QB: 0
EPS next Quarter (2026-03-31): EPS=3.52 | Chg30d=-2.377 | Revisions Net=-3 | Analysts=9
EPS next Year (2026-12-31): EPS=21.67 | Chg30d=-3.432 | Revisions Net=-20 | Growth EPS=+20.4% | Growth Revenue=+5.1%